FINWIRES · TerminalLIVE
FINWIRES

SoftBank Surges Past Toyota to Become Japan's Most Valuable Firm; Shares Up 10%

By

Shares of SoftBank Group (TYO:9984) rose sharply in Monday's early trading session, pushing its market capitalization to over 47 trillion yen, making it the most valuable company on the Tokyo exchange for the first time in over two decades.

The tech conglomerate's stock jumped over 10% to 8,259 yen at 11:30 am in Tokyo on Monday.

SoftBank has overtaken the long-time leader, Toyota Motor (TYO:7203), and now holds a market value of 45.7 trillion yen.

Toyota's shares fell 4.8% in recent trade.

Related Articles

Asia

ASX Midday Sector Update: Information Technology Stocks Jump, Healthcare Sector Falls

Information technology stocks advanced more than 5% at midday Monday.Xero (ASX:XRO) gained 8% in recent trade.On the flip side, the healthcare sector struggled, shedding nearly 2%.CSL (ASX:CSL) shares fell almost 2% in recent trade.

$^AXJO$ASX:CSL$ASX:XRO
Asia

Naipu Mining Machinery Enters Three-Year Partnership With Zijin Mining; Shares Jump 6%

Naipu Mining Machinery (SHE:300818) signed a three-year strategic cooperation agreement with Zijin Mining Group (SHA:601899, HKG:2899), effective May 14.Under the deal, the company will supply slurry pumps and wear-resistant parts, with priority order fulfillment during capacity constraints, according to a Monday filing with the Shenzhen bourse.The agreement includes full lifecycle equipment management, joint research and development for extended equipment life, overseas project collaboration and consignment inventory models.Shares of the mining equipment and spare parts distributor rose 6% in recent trade.

$HKG:2899$SHA:601899$SHE:300818
Asia

Peijia Medical Unit Wins China Distribution Rights for B. Braun Intracranial Balloon Catheter

Peijia Medical (HKG:9996) subsidiary Achieva Medical entered into a distribution agreement with B. Braun Medical for the mainland China distribution of the SeQuent Please CIS paclitaxel drug-coated intracranial balloon dilatation catheter, according to a Monday Hong Kong bourse filing.The product is designed to treat intracranial vascular diseases and to deliver paclitaxel precisely to diseased blood vessel walls during balloon dilatation to reduce the risk of restenosis.

$HKG:9996